Skip to content

Effect of Isometric Handgrip Training on Cardiovascular Risk in Hypertensives

Effect of Isometric Handgrip Training on Cardiovascular Risk in Hypertensives

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02348138
Enrollment
72
Registered
2015-01-28
Start date
2015-06-30
Completion date
2016-12-31
Last updated
2017-10-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Keywords

Isometric Handgrip

Brief summary

The main purpose this study is to analyze the effects of isometric handgrip training on cardiovascular risk in hypertensive. For this, approximately 60 hypertensive, under anti-hypertensive medication, will be selected and randomly distributed into three groups: home-based isometric handgrip training (HBT), supervised isometric handgrip training (ST) and control group (CG).Subjects assigned to the HBT and ST will train three times per week for a total of 12 weeks, will perform a bout of isometric handgrip exercise: four sets of 2-min isometric contractions (using alternate hands) at 30% of maximal voluntary contraction. However, the subjects of the HBT group conduct the training without daily supervision. Subjects randomized to the CG will be encouraged to increase the level of physical activity and make healthy eating, without, however, receive specific recommendations.Baseline and after 12 weeks of intervention, the following cardiovascular risk indicators will be obtained: blood pressure, arterial stiffness, cardiac autonomic modulation, vasodilatory capacity and oxidative and inflammatory stress markers, in addition to microalbuminuria. For data analysis, in addition to descriptive statistics, two-way ANOVA for mixed model will be applied for within and between groups comparison. If the premises of this test are met. The level of significance that will be adopted is p\<0.05.

Interventions

The two experimental groups (HBT and ST) will receive intervention with isometric handgrip exercise for 12 weeks, and the HBT group without daily supervision.

Sponsors

Conselho Nacional de Desenvolvimento Científico e Tecnológico
CollaboratorOTHER_GOV
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
CollaboratorOTHER_GOV
Fundação de Amparo à Ciência e Tecnologia de Pernambuco
CollaboratorOTHER
University of Pernambuco
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Clinical diagnosis of hypertension; * Must be under anti-hypertensive medications of three months or more; * May not present diabetes or other cardiovascular diseases; * May not engaged in regular physical activity; * May not have disabilities that compromise the physical activity practices.

Exclusion criteria

* Not perform more than 85% of the training sessions; * Present diagnosis of metabolic diseases, cardiovascular or pulmonary during the study; * Adherence to other physical activity program beyond the training offered by this study; * Change in class and / or dose of medication during the study; * Not using the medication regularly; * Worsening of the disease.

Design outcomes

Primary

MeasureTime frame
Change in office blood pressureBaseline and 12 weeks

Secondary

MeasureTime frame
Change in ambulatory blood pressureBasaline and 12 weeks
Change in central blood pressureBasaline and 12 weeks
Change in cardiac autonomic modulationBaseline and 12 weeks
Change in vasodilatory capacityBaseline and 12 weeks
Change in markers of oxidative stressBaseline and 12 weeks
Change in markers of inflammationBaseline and 12 weeks
Change in arterial stiffnessBaseline and 12 weeks

Other

MeasureTime frameDescription
Adherence to training12 weeksAdherence to training will be evaluated by the number of subjects who completed the two types of training
Change in handgrip strengthBaseline and 12 weeks

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026